Sort   by:  
 Page size 
UnknownPooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancer.
Not available
S-EPMC9808443 | biostudies-literature
UnknownQuality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRC.
Not available
S-EPMC9271477 | biostudies-literature
UnknownA phase I, open-label, multicentre, first-in-human study to evaluate safety, pharmacokinetics and efficacy of AMG 404, a PD-1 inhibitor, in patients with advanced solid tumours.
Not available
S-EPMC12049887 | biostudies-literature
UnknownPhase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma.
Not available
S-EPMC5054695 | biostudies-literature
UnknownResults from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma.
Not available
S-EPMC10251876 | biostudies-literature
UnknownEncorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study.
Not available
S-EPMC8078423 | biostudies-literature
UnknownSystematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer.
Not available
S-EPMC6276906 | biostudies-literature
UnknownTislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study.
Not available
S-EPMC9462531 | biostudies-literature
UnknownEntrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials.
Not available
S-EPMC7811790 | biostudies-literature
UnknownEfficacy of Zenocutuzumab in <i>NRG1</i> Fusion-Positive Cancer.
Not available
S-EPMC11878197 | biostudies-literature
Sort   by:  
 Page size